https://webnewsinsider.com/flawed-studies-prompt-hormone-therapy-caution-for-breast-cancer-survivors/ WebNewsInsider en 2026-11-01T23:25:07+08:00 Flawed Studies Prompt Hormone Therapy Caution for Breast Cancer Survivors https://webnewsinsider.com/great-lakes-over-6400-oil-spills-over-a-decade/ WebNewsInsider en 2026-11-01T15:33:11+08:00 Great Lakes: Over 6,400 Oil Spills Over a Decade https://webnewsinsider.com/histotripsy-fda-clears-non-invasive-cancer-treatment-hope4liver-trial-shows-promising-results/ WebNewsInsider en 2026-11-01T13:11:20+08:00 Histotripsy: FDA Clears Non-Invasive Cancer Treatment, HOPE4LIVER Trial Shows Promising Results https://webnewsinsider.com/october-fda-approvals-offer-rare-disease-hope-across-five-medical-specialties/ WebNewsInsider en 2026-11-01T07:23:21+08:00 October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease https://webnewsinsider.com/jaist-bacteria-study-eradicates-tumors-in-mice-without-immune-system-help/ WebNewsInsider en 2026-11-01T01:26:39+08:00 Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People https://webnewsinsider.com/dendritic-cell-cancer-vaccines-one-fda-approval-many-unproven-clinic-offers/ WebNewsInsider en 2026-11-01T01:22:22+08:00 Dendritic Cell Cancer Vaccines: One FDA Approval, Most Others Still in Trials https://webnewsinsider.com/car-t-cell-therapy-explained-how-it-works-approved-blood-cancers-and-key-risks/ WebNewsInsider en 2026-11-01T01:18:01+08:00 CAR-T Cell Therapy Explained: How It Works, Approved Blood Cancers, and Key Risks https://webnewsinsider.com/cancer-related-financial-toxicity-explained-how-insurance-gaps-cause-bankruptcy/ WebNewsInsider en 2026-10-31T21:23:24+08:00 Nicole Eggert’s Cancer Bills and a Trial That Cut Financial Toxicity for Patients https://webnewsinsider.com/moderna-merck-vaccine-beats-keytruda-alone-in-melanoma-trial/ WebNewsInsider en 2026-10-31T11:50:02+08:00 Could the Moderna-Merck Melanoma Vaccine Win FDA Approval Within Two Years? What We Know https://webnewsinsider.com/bms-ryz101-meets-phase-3-goal-in-neuroendocrine-tumors-after-lutetium-177-failure/ WebNewsInsider en 2026-10-31T07:51:35+08:00 BMS RYZ101 Meets Phase 3 Goal in Neuroendocrine Tumors After Lutetium-177 Failure https://webnewsinsider.com/epitalon-peptide-shows-mixed-results-in-lab-studies-on-telomeres-and-cancer/ WebNewsInsider en 2026-10-31T03:12:47+08:00 Epitalon Peptide Shows Mixed Results in Lab Studies on Telomeres and Cancer https://webnewsinsider.com/early-breast-cancer-treatments-symptoms-and-survival/ WebNewsInsider en 2026-10-31T02:00:00+08:00 How Early-Stage Breast Cancer Is Treated: Surgery, Radiation and Whole-Body Therapy https://webnewsinsider.com/why-retirees-must-shift-emergency-fund-strategies-beyond-standard-three-month-rules/ WebNewsInsider en 2026-10-31T01:12:11+08:00 Why Retirees Must Shift Emergency Fund Strategies Beyond Standard Three-Month Rules https://webnewsinsider.com/how-new-immunotherapy-aims-to-break-the-cycle-of-surgery-for-rrp-patients/ WebNewsInsider en 2026-10-31T00:27:02+08:00 How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients https://webnewsinsider.com/biosapien-begins-first-in-human-medichip-trial-for-rectal-cancer-at-burjeel/ WebNewsInsider en 2026-10-31T00:26:38+08:00 BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel